Exmar NV (LON:0EEV)
London flag London · Delayed Price · Currency is GBP · Price in EUR
11.74
-0.18 (-1.51%)
At close: Aug 1, 2025

Theseus Pharmaceuticals Revenue

In the year 2024, Exmar NV had annual revenue of $348.91M USD, down -28.40%. Exmar NV had revenue of $70.01M in the quarter ending December 31, 2024, a decrease of -50.67%.

Revenue
$348.91M
Revenue Growth
-28.40%
P/S Ratio
2.22
Revenue / Employee
$229.40K
Employees
1,521
Market Cap
619.96M

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024348.91M-138.41M-28.40%
Dec 31, 2023487.32M331.71M213.18%
Dec 31, 2022155.60M7.38M4.98%
Dec 31, 2021148.23M-136.93M-48.02%
Dec 31, 2020285.15M146.93M106.30%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Shell217.54B
BP p.l.c.143.50B
DCC plc18.01B
Harbour Energy4.97B
Ithaca Energy1.71B
Energean1.05B
Seplat Energy1.53B
Yellow Cake-353.03M
Revenue Rankings